Searching journal content for thyroid cancer (as phrase) in full text.

Displaying results 1-10 of 431
For checked items
  1. ...gene expression, that can be 128 translated in differences in tumor microenvironment, and ultimately in disease severity in 129 MTC (Engelmann, et al. 2009). 130 131 Page 6 of 38 7 3. The role of microenvironment in thyroid cancer: FTC vs MTC 132 Human tumors must not be considered as simple masses ~~~
  2. ...the overtreatment of low-risk and on the other hand the undertreatment of high-risk patients. The question how to properly assess the risk of relapse has been discussed during recent years and resulted in a substantial change in our approach to risk stratification in differentiated thyroid cancer, proposed ~~~
  3. .... The physical interaction of -catenin and TR was also demonstrated in a mouse model of thyroid cancer. T3 binding to TR weakened the -catenin/TR interaction, increasing the amount of -catenin available to be degraded via the proteasomal pathway (Guigonetal. 2008). -Catenin also interacts with TR1 ~~~
  4. ...-293-5264 24 25 Abstract: 169 26 Word count: 4749 27 Figures: 8 28 Keywords: Succinate dehydrogenase, Thyroid cancer, Stem cells, Metabolism, Mouse models 29 30 Page 1 of 37 Accepted Preprint first posted on 19 September 2017 as Manuscript ERC-17-0229 Copyright 2017 by the Society for Endocrinology. ABSTRACT ~~~
  5. ...Immune responses in the thyroid cancer microenvironment: making 1 immunotherapy a possible mission 2 3 Robert C. Mould, Jacob P. van Vloten, Amanda W. K. AuYeung, Khalil Karimi, Byram 4 W. Bridle* 5 Department of Pathobiology, University of Guelph, Guelph, Ontario, Canada 6 contributed equally 7 ~~~
  6. ...neoplasia-type 1. Science 276 404407. (doi:10.1126/ science.276.5311.404) Chiappetta G, De Marco C, Quintiero A, Califano D, Gherardi S, Malanga D, Scrima M, Montero-Conde C, Cito L, Monaco M, etal. 2007 Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer. Endocrine-Related Cancer ~~~
  7. ...describe 27 the most essential concepts related to immune checkpoint inhibitors. We critically review the 28 literature on preclinical and clinical studies of the immune checkpoint inhibitors as a treatment 29 option for thyroid cancer, ovarian carcinoma, pancreatic adenocarcinoma, adrenocortical 30 ~~~
  8. ...this uncommon disease, can be eliminated in our lifetime. 59 60 Page 2 of 33 1. Introduction (Word Count: 4117) 61 62 More than fifty years ago, the medical community witnessed the birth of a new hereditary endocrine 63 syndrome encompassing medullary thyroid cancer (MTC) and pheochromocytoma: Sipple syndrome ~~~
  9. ...and HRPT2 40 related HPTH are briefly described, with a focus on the most recent literature data, 41 and is compared with familial hypocalciuric hypalcemia. 42 43 44 Page 2 of 36 1. INTRODUCTION 45 The majority of the studies published on MEN2 focused on medullary thyroid cancer 46 (MTC), as it represents ~~~
  10. ...RNAs to carcinogenesis has been reported in recent years. miRNAs seem to be promising diagnostic and prognostic molecular markers for thyroid cancer, and the combination of miRNA expression and mutational status might improve cytological diagnosis. The aim of the present study was to evaluate the miRNA expression ~~~
For checked items